This is consistent with our previous data showing that Eμ-Myc lymphoma cells treated with CX-5461, a highly selective inhibitor of Pol I-mediated transcription36, are over 100-fold less sensitive to apoptotic cell death following BCL2 overexpression37. Here, BCL2 is linked to lymphoma.